Tech Meridian
← ENTITY INDEX
COMPANY · ENTITY #19480
Related event timeline, sources and context from the news index.
OpenAI is acquiring Orchestra Bio to integrate AI-powered operations into life‑sciences R&D, aiming to help biopharma teams accelerate drug development and advance new treatments. The move positions OpenAI to extend its AI capabilities into laboratory and research workflows in the life‑sciences sector.
The Rosalind Academic Plan was announced to give eligible academic labs sponsored access to GPT-Rosalind and accompanying tools aimed at advancing life‑sciences research. The program targets academic research groups rather than commercial users and emphasizes enabling lab use of the model for scientific work.
Allow Google Analytics to measure visits? It stays off until you choose. You can change your choice at any time.